Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Head and Neck Cancer”

1,733 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,733 results

Testing effectiveness (Phase 2)Study completedNCT03866967
What this trial is testing

Anti-PD-1 AK105 in Patients With Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Carcinoma
Akeso 130
Not applicableNot Yet RecruitingNCT06091878
What this trial is testing

Gene Expression Profiling in a Validation Cohort of Locally Advanced and Recurrent/Metastatic Salivary Gland Cancers

Who this might be right for
Salivary Gland Cancer
Royal Marsden NHS Foundation Trust 250
Testing effectiveness (Phase 2)Ended earlyNCT01313390
What this trial is testing

Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
University College, London 4
Testing effectiveness (Phase 2)Study completedNCT00101348
What this trial is testing

Erlotinib and Cetuximab With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney, Colorectal, Head and Neck, Pancreatic, or Non-Small Cell Lung Cancer

Who this might be right for
Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the Lip+64 more
National Cancer Institute (NCI) 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT03370276
What this trial is testing

Cetuximab & Nivolumab in Patients With Recurrent/Metastatic Head & Neck Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the OropharynxSquamous Cell Carcinoma of the LarynxSquamous Cell Carcinoma of the Oral Cavity+5 more
H. Lee Moffitt Cancer Center and Research Institute 95
Early research (Phase 1)Not Yet RecruitingNCT07216833
What this trial is testing

Decitabine and Nivolumab in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Head and Neck CancerHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma
Kyunghee Burkitt, DO, PhD 15
Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Testing effectiveness (Phase 2)Looking for participantsNCT05420948
What this trial is testing

Pembrolizumab in Combination With Chemotherapy for Head and Neck Cancer

Who this might be right for
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHead and Neck Neoplasms+2 more
University of Chicago 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05010629
What this trial is testing

9-ING-41 Plus Carboplatin in Salivary Gland Carcinoma

Who this might be right for
Salivary Gland CancerRecurrent Salivary Gland CancerMetastatic Cancer+1 more
Glenn J. Hanna 35
Testing effectiveness (Phase 2)Ended earlyNCT03320629
What this trial is testing

Apatinib Plus Radiotherapy and S-1 for Treatment of Refractory or Metastatic Esophageal Squamous Cell Carcinoma

Who this might be right for
Refractory or Metastatic Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 7
Testing effectiveness (Phase 2)Study completedNCT02280811
What this trial is testing

T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers

Who this might be right for
Vaginal CancerCervical CancerAnal Cancer+2 more
National Cancer Institute (NCI) 12
Testing effectiveness (Phase 2)UnknownNCT01830504
What this trial is testing

Phase II Pilot Open Label

Who this might be right for
Thyroid Cancers
Hospices Civils de Lyon 47
Testing effectiveness (Phase 2)Study completedNCT00095901
What this trial is testing

Capecitabine For Nasopharyngeal Cancer

Who this might be right for
Head and Neck Cancer
Dana-Farber Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT00017043
What this trial is testing

BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy

Who this might be right for
Esophageal CancerGastric Cancer
Bristol-Myers Squibb
Early research (Phase 1)Looking for participantsNCT06469008
What this trial is testing

BL-B16D1 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomasSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT01349933
What this trial is testing

Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Recurrent Squamous Cell Carcinoma of the NasopharynxStage IV Squamous Cell Carcinoma of the Nasopharynx
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Ended earlyNCT05551117
What this trial is testing

Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid Tumors

Who this might be right for
Castration-Resistant Prostatic CancerAndrogen-Independent Prostatic CancerAndrogen-Insensitive Prostatic Cancer+14 more
MacroGenics 192
Testing effectiveness (Phase 2)Study completedNCT01164176
What this trial is testing

Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer

Who this might be right for
Head and Neck Cancer
Yonsei University 40
Testing effectiveness (Phase 2)Looking for participantsNCT06769113
What this trial is testing

A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy

Who this might be right for
Esophageal Cancer
Shanghai Henlius Biotech 72
Early research (Phase 1)UnknownNCT03282617
What this trial is testing

Dendritic Cell Therapy With CD137L-DC-EBV-VAX in Locally Advanced Stage IV or Locally Recurrent/Metastatic Nasopharyngeal Carcinoma

Who this might be right for
Nasopharyngeal Cancer
National University Hospital, Singapore 55
Load More Results